Id	Study	Session	StudySession	SL	TL	Task	Text	Part	SGroup	TGroup	STid	SGid	STseg	TokS	LenS	TTid	TGid	TTseg	TokT	LenT	Ins	Del	Munit	InEff	FixS	TrtS	OrtS	OrtT	MU1rtS	MU1rtT	FFTimeS	FFDurS	FixT	TrtT	FFTimeT	FFDurT	CrossS	CrossT	Pause	Dur	End	Edit	Pause1	Time1	Ins1	Del1	Dur1	End1	Edit1	Pause2	Time2	Ins2	Del2	Dur2	End2	Edit2	PauseR	TimeR	InsR	DelR	DurR	EditR	Edit
1	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	How	Wie	1	1	1	1	3	1	1	1	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
2	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	does_work	arbeitet	2	2+4	1	2	8	2	2	1	1	9	22	4	1	1.4211	0	0	0	0	0	0	0	0	0	0	0	0	1	3	9376	7644	390065	arbeiet[te]tet_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	9376	382421	11	2	3666	arbeiet[te]tet_[	arbeiet[te]tet_
3	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	3	3	1	1	8	3	3	1	1	8	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-1	531	22604	414853	_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	531	392249	0	1	0	_	_
4	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	?	?	5	5	1	1	1	4	4	1	1	1	0	22	1	-1.0952	0	0	0	0	0	0	0	0	0	0	0	0	1	2	3978	2184	392249	[zu_arbeiten	0	0	0	0	0	0	---	0	0	0	0	0	0	---	3978	390065	0	11	1653	zu_arbeiten	[zu_arbeiten
5	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	The	Der	6	6	2	1	3	5	5	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
6	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	active_substance	Wirkstoff	7	7+8	2	2	15	6	6	2	1	16	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
7	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	in	in	9	9	2	1	2	7	7	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
8	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	10	10	2	1	8	8	8	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
9	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,	,	11	11	2	1	1	9	9	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
10	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	topotecan	Topotecan	12	12	2	1	9	10	10	2	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
11	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,	,	13	13	2	1	1	11	11	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
12	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	is	ist	14	14	2	1	2	12	12	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
13	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	an	ein	15	15	2	1	2	13	13	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
14	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	anticancer	gegen_Krebs	16	16	2	1	10	15	15+16	2	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
15	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	medicine	Arzneimittel	17	17	2	1	8	14	14	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
16	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	that	,_das	18	18	2	1	4	17	17+18	2	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
17	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	belongs	gehört	19	19	2	1	7	27	27	2	1	7	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	1857	1872	418582	[gehört_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1857	416710	1	0	0	gehört_	[gehört_
18	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	to_the	zur	20	20+21	2	2	5	19	19	2	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-8	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
19	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	group	Gruppe	22	22	2	1	5	20	20	2	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
20	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	""""	""""	23	23	2	1	1	22	22	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
21	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	topoisomerase	Topoisomerase_-	24	24	2	1	13	23	23+24	2	2	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
22	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	inhibitors	Hemmer	25	25	2	1	10	25	25	2	1	10	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	22604	1857	416710	.	0	0	0	0	0	0	---	0	0	0	0	0	0	---	22604	414853	0	1	0	.]	.
23	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	26	26	2	1	1	28	28	2	1	1	2	2	1	5.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	1872	16380	434962	.[_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	1872	418582	1	1	1528	.[_	.[_
24	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	It	Es	28	28	3	1	2	29	29	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
25	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	blocks	blockiert	29	29	3	1	6	30	30	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
26	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	an	das	30	30	3	1	2	31	31	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
27	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	enzyme	Enzym	31	31	3	1	6	32	32	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
28	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	topoisomerase	Topoisomerase	33	33	3	1	13	33	33	3	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
29	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	I	I	34	34	3	1	1	34	34	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
30	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,	,	35	35	3	1	1	35	35	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
31	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	which	das	36	36	3	1	5	36	36	3	1	5	4	6	1	-11.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	150291	9594	159885	[ei]as[i	150291	150291	2	3	9516	159807	ei]as[i]	0	0	0	0	0	0	---	0	0	0	0	0	---	[ei]as[i
32	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	is	ist	37	37	3	1	2	43	43	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
33	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	involved	beteiligt	38	38	3	1	8	42	42	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
34	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	in	an	39	39	3	1	2	37	37	3	1	2	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	78	3495	163380	[a	78	159885	1	0	0	159885	a[	0	0	0	0	0	0	---	0	0	0	0	0	---	[a
35	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	der	40	40	3	1	3	38	38	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
36	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	division	Teilung	41	41	3	1	8	39	39	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
37	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	of	der	42	42	3	1	2	40	40	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
38	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	DNA	DNS	43	43	3	1	3	41	41	3	1	3	2	2	1	5.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	3495	24554	187934	[A]S	3495	163380	1	1	889	164269	A]S[	0	0	0	0	0	0	---	0	0	0	0	0	---	[A]S
39	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	44	44	3	1	1	44	44	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
40	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	an	---	27	89	3	1	2	0	0	0	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	45	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
41	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	an	---	32	89	3	1	2	0	0	0	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
42	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	When	Wenn	45	45	4	1	4	45	45	4	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	-44	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
43	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	das	46	46	4	1	3	46	46	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
44	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	enzyme	Enzym	47	47	4	1	6	47	47	4	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
45	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	is	ist	48	48	4	1	2	49	49	4	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
46	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	blocked	blockiert	49	49	4	1	7	48	48	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
47	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,	,	50	50	4	1	1	50	50	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
48	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	die	51	51	4	1	3	52	52	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
49	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	DNA	DNS_-	52	52	4	1	3	53	53+54	4	2	2	2	2	1	5.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	14852	58016	492978	A]S	0	0	0	0	0	0	---	0	0	0	0	0	0	---	14852	434962	1	1	452	A]S[	A]S
50	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	strands	Stränge	53	53	4	1	7	55	55	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
51	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	break	brechen	54	54	4	1	5	51	51	4	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
52	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	55	55	4	1	1	56	56	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
53	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	This	Dies	56	56	5	1	4	57	57	5	1	4	0	6	1	-1.4000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	23665	1794	189728	[rev	23665	187934	0	3	718	188652	rev	0	0	0	0	0	0	---	0	0	0	0	0	---	[rev
54	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	prevents	hindert_an	57	57	5	1	8	58	58+61	5	2	7	0	4	1	-1.6667	0	0	0	0	0	0	0	0	0	0	0	0	4	1	1076	4899	194627	,dass_	1076	189728	0	2	842	190570	,dass_	0	0	0	0	0	0	---	0	0	0	0	0	---	,dass_
55	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	die	58	58	5	1	3	59	59	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
56	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	cancer_cells	Krebszellen	59	59+60	5	2	11	60	60	5	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
57	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	from	der	61	61	5	1	4	62	62	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
58	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	dividing	Teilung	62	62	5	1	8	63	63	5	1	8	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	4057	18595	213222	,	4057	194627	0	1	0	194627	,]	0	0	0	0	0	0	---	0	0	0	0	0	---	,
59	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	and	und	63	63	5	1	3	64	64	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
60	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	they	sie	64	64	5	1	4	65	65	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
61	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	eventually	schließlich	65	65	5	1	10	67	67	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
62	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	die	sterben_ab	66	66	5	1	3	66	66+68	5	2	2	20	2	1	1.2105	0	0	0	0	0	0	0	0	0	0	0	0	1	1	18595	21293	234515	[sterben_[sterben]ab	18595	213222	10	1	5897	219119	sterben_[sterben]ab[	0	0	0	0	0	0	---	0	0	0	0	0	---	[sterben_[sterben]ab
63	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	67	67	5	1	1	69	69	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
64	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	68	68	6	1	8	70	70	6	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
65	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	also	auch	69	69	6	1	4	73	73	6	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
66	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	affects	wirkt_sich_auf_aus	70	70	6	1	7	71	71+72+74+78	6	4	4	6	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	250	6395	254499	aus	250	248104	3	0	1216	249320	aus[	0	0	0	0	0	0	---	0	0	0	0	0	---	aus
67	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	non	Nicht	71	71	6	1	3	75	75	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
68	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	-	-	72	72	6	1	1	76	76	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
69	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	cancer_cells	Krebszellen	73	73+74	6	2	11	77	77	6	1	12	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	12776	250	248104	_	12776	247854	1	0	0	247854	_	0	0	0	0	0	0	---	0	0	0	0	0	---	_
70	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,	,	75	75	6	1	1	79	79	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
71	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	which	was	76	76	6	1	5	80	80	6	1	5	8	2	1	1.5714	0	0	0	0	0	0	0	0	0	0	0	0	1	1	15396	13339	247854	[die_]was_	15396	234515	4	1	563	235078	die_]was_	0	0	0	0	0	0	---	0	0	0	0	0	---	[die_]was_
72	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	causes	verursacht	77	77	6	1	6	82	82	6	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
73	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	side_effects	Nebenwirkungen	78	78+79	6	2	11	81	81	6	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
74	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	80	80	6	1	1	83	83	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
75	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	How	Wie	81	81	7	1	3	84	84	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
76	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	has_been	wurde	82	82+84	7	2	7	85	85	7	1	8	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	3	5179	33649	288148	[hat_]wurde_	5179	254499	6	1	703	255202	hat_]wurde_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[hat_]wurde_
77	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	83	83	7	1	8	86	86	7	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	-1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
78	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	studied	untersucht	85	85	7	1	7	87	87	7	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
79	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	?	?	86	86	7	1	1	88	88	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
80	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	87	87	8	1	8	89	89	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
81	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	as	als	88	88	8	1	2	90	90	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
82	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	infusion	Infusion	90	90	8	1	8	91	91	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
83	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	has_been	wurde	91	91+92	8	2	7	92	92	8	1	8	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	2	32946	4244	292392	[hat_]wurde_	32946	288148	6	1	875	289023	hat_]wurde_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[hat_]wurde_
84	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	studied	untersucht	93	93	8	1	7	113	113	8	1	7	0	4	1	-1.6667	0	0	0	0	0	0	0	0	0	0	0	0	21	1	7441	8844	315807	[worden_	7441	306963	0	2	405	307368	worden_	0	0	0	0	0	0	---	0	0	0	0	0	---	[worden_
85	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	in	in	94	94	8	1	2	93	93	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-20	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
86	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	more	mehr	95	95	8	1	4	94	94	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
87	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	than	als	96	96	8	1	4	95	95	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
88	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	480	480	97	97	8	1	3	96	96	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
89	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	women	Frauen	98	98	8	1	5	97	97	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
90	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	with	mit	99	99	8	1	4	98	98	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
91	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	ovarian_cancer	Eierstockkrebs	100	100+101	8	2	13	99	99	8	1	14	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	3369	5865	298257	[_	3369	292392	0	1	0	292392	_	0	0	0	0	0	0	---	0	0	0	0	0	---	[_
92	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	who	,_bei_denen	102	102	8	1	3	100	100+101+102	8	3	1	20	2	1	1.2105	0	0	0	0	0	0	0	0	0	0	0	0	3	1	5865	8706	306963	die_]bei_denen_	5865	298257	10	1	1265	299522	die_]bei_denen_[	0	0	0	0	0	0	---	0	0	0	0	0	---	die_]bei_denen_
93	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	had	war	103	103	8	1	3	111	111	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
94	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	failed	gescheitert	104	104	8	1	6	110	110	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
95	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	one	eine	105	105	8	1	3	103	103	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
96	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	treatment	Behandlung	106	106	8	1	9	104	104	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
97	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	with	mit	107	107	8	1	4	105	105	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
98	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	platinum_-_containing	platinhaltigen	108	108+109+110	8	3	19	106	106	8	1	21	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
99	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	anticancer	gegen_Krebs	111	111	8	1	10	108	108+109	8	2	9	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	57564	19204	512182	[,	0	0	0	0	0	0	---	0	0	0	0	0	0	---	57564	492978	0	1	0	,	[,
100	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	medicines	Arzneimitteln	112	112	8	1	9	107	107	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
101	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	113	113	8	1	1	114	114	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
102	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Three	Drei	114	114	9	1	5	115	115	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
103	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	studies	Studien	115	115	9	1	7	116	116	9	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
104	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	were	waren	116	116	9	1	4	117	117	9	1	4	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	1	8439	21233	337040	seien_]waren_	8439	315807	6	1	906	316713	seien_]waren_	0	0	0	0	0	0	---	0	0	0	0	0	---	seien_]waren_
105	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	""""	""""	117	117	9	1	1	118	118	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
106	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	open	offen	118	118	9	1	4	119	119	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
107	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,	,	119	119	9	1	1	121	121	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
108	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	""""	""""	120	120	9	1	1	120	120	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
109	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	meaning	was_bedeutet	121	121	9	1	7	122	122+123	9	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
110	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	that	,_dass	122	122	9	1	4	124	124+125	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
111	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	das	123	123	9	1	3	126	126	9	1	3	38	40	1	-79.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	19204	28938	541120	Medizin__ei]as_[_sa]er_Wirkstoff_[_ffotskriW_re]as_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	19204	512182	19	20	28689	Medizin__ei]as_[_sa]er_Wirkstoff_[_ffotskriW_re]as_	Medizin__ei]as_[_sa]er_Wirkstoff_[_ffotskriW_re]as_
112	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	medicine	Arzneimittel	124	124	9	1	8	127	127	9	1	8	26	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	249	13432	554552	Arzneimittel_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	249	541120	13	0	1841	Arzneimittel_[	Arzneimittel_
113	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	was	wurde	125	125	9	1	3	134	134	9	1	3	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	20327	12730	349770	wurde_	20327	337040	6	0	842	337882	wurde_[	0	0	0	0	0	0	---	0	0	0	0	0	---	wurde_
114	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	not	nicht	126	126	9	1	3	128	128	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-6	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
115	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	compared	verglichen	127	127	9	1	8	133	133	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
116	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	to	mit	128	128	9	1	2	129	129	9	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
117	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	any	einer	129	129	9	1	3	130	130	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
118	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	other	anderen	130	130	9	1	5	131	131	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
119	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	treatment	Behandlung	131	131	9	1	9	132	132	9	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
120	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	and	und	132	132	9	1	3	135	135	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
121	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	die	133	133	9	1	3	136	136	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
122	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	patients	Patienten	134	134	9	1	8	137	137	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
123	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	knew	wussten	135	135	9	1	4	138	138	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
124	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	that	,_dass	136	136	9	1	4	139	139+140	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
125	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	they	sie	137	137	9	1	4	141	141	9	1	4	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	11591	2044	556596	[erhielten_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	11591	554552	0	1	0	erhielten_]	[erhielten_
126	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	were_receiving	erhielten	138	138+139	9	2	13	143	143	9	1	14	2	2	1	5.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	702	1341	558639	erhielten_[_]	0	0	0	0	0	0	---	0	0	0	0	0	0	---	702	557298	1	1	1341	erhielten_[_]	erhielten_[_]
127	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	140	140	9	1	8	142	142	9	1	8	2	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	2044	702	557298	[_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	2044	556596	1	0	0	_	[_
128	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	141	141	9	1	1	144	144	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
129	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	The	Die	142	142	10	1	3	145	145	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
130	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	fourth	vierte	143	143	10	1	6	146	146	10	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
131	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	study	Studie	144	144	10	1	5	147	147	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
132	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	involved	umfasste	145	145	10	1	8	148	148	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
133	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	226	226	146	146	10	1	3	149	149	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
134	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	women	Frauen	147	147	10	1	5	150	150	10	1	5	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	11888	6520	356290	[,	11888	349770	0	1	0	349770	,	0	0	0	0	0	0	---	0	0	0	0	0	---	[,
135	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	,_and	und	148	148+149	10	2	4	151	151	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
136	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	compared	verglich	150	150	10	1	8	152	152	10	1	8	0	4	1	-1.6667	0	0	0	0	0	0	0	0	0	0	0	0	1	1	6520	15694	371984	ne	6520	356290	0	2	172	356462	ne]	0	0	0	0	0	0	---	0	0	0	0	0	---	ne
137	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	Hycamtin	Hycamtin	151	151	10	1	8	153	153	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
138	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	with	mit	152	152	10	1	4	154	154	10	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
139	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	paclitaxel	Paclitaxel	153	153	10	1	10	155	155	10	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
140	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	(	(	154	154	10	1	1	156	156	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
141	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	another	ein_anderes	155	155	10	1	7	157	157+158	10	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
142	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	anticancer	gegen_Krebs	156	156	10	1	10	160	160+161	10	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
143	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	medicine	Arzneimittel	157	157	10	1	8	159	159	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
144	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	)	)	158	158	10	1	1	162	162	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
145	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	159	159	10	1	1	163	163	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
146	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	The	Der	160	160	11	1	3	164	164	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
147	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	main_measure	Hauptindikator	161	161+162	11	2	11	165	165	11	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
148	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	of	für	163	163	11	1	2	166	166	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
149	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	effectiveness	Wirksamkeit	164	164	11	1	13	168	168	11	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
150	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	was	war	165	165	11	1	3	169	169	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
151	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	the	die	166	166	11	1	3	170	170	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
152	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	number	Anzahl	167	167	11	1	6	171	171	11	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
153	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	of	der	168	168	11	1	2	172	172	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
154	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	patients	Patienten	169	169	11	1	8	173	173	11	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
155	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	whose	,_deren	170	170	11	1	5	174	174+175	11	2	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
156	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	tumours	Tumoren	171	171	11	1	7	176	176	11	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
157	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	responded	ansprachen	172	172	11	1	9	180	180	11	1	9	16	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	15522	10437	382421	[sprachen	15522	371984	8	0	1061	373045	sprachen	0	0	0	0	0	0	---	0	0	0	0	0	---	[sprachen
158	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	to	auf	173	173	11	1	2	177	177	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
159	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	treatment	Behandlung	174	174	11	1	9	179	179	11	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
160	OCT13	P26_PL03	OCT13@P26_PL03	en	de	PL	03	P26	.	.	175	175	11	1	1	181	181	11	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---